Chlorantraniliprole Market is expected to grow at a CAGR of 4.9% during the forecasted period | Evolve Business Intelligence

Key Highlights:
• The global Chlorantraniliprole Market size was valued at USD 1886.8 million in 2022 growing at a CAGR of 4.9% from 2023 to 2033.
• North America dominated the market in 2022
• Asia Pacific is expected to grow at the highest CAGR from 2023 to 2033

As per the study initiated by Evolve Business Intelligence, the global Chlorantraniliprole Market size accounted for USD 1886.8 million in 2022, growing at a CAGR of 4.9% from 2023 to 2033. The chlorantraniliprole market involves a chemical compound used as an insecticide in agriculture. Belonging to the diamide class, chlorantraniliprole acts on insect pests by targeting their ryanodine receptors, disrupting their muscle function and leading to mortality. Widely employed in crop protection, particularly on crops like rice, corn, and vegetables, chlorantraniliprole is known for its effectiveness against lepidopteran pests. The market's growth is driven by the continuous demand for efficient insecticides, advancements in pest control technologies, and the expansion of agriculture globally. Chlorantraniliprole is recognized for its selective action and reduced environmental impact compared to traditional insecticides.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=openpr.com&reportCode=021732

The chlorantraniliprole market is propelled by the increasing demand for effective insecticides in agriculture, with a focus on crop protection against lepidopteran pests. Its selective action on ryanodine receptors, leading to improved muscle function disruption in insects, contributes to its popularity. The market's growth is further driven by advancements in pest control technologies, expanding global agriculture, and the recognition of chlorantraniliprole for its efficacy and reduced environmental impact compared to traditional insecticides.

Key Players
Some of the major Chlorantraniliprole Market players holding high market shares include B JOSHI AGROCHEM PHARMA, Bayer CropScience, Bioseen, DuPont and Dow.These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include FMC Corporation, Nihon Nohyaku, Shanghai Shengnong Pesticide, Shenyang Sciencreat Chemicals, STAR BIO SCIENCE and Syngenta.

Report Description: https://report.evolvebi.com/index.php/sample/request?referer=openpr.com&reportCode=021732

Segmental Analysis
Based on product type, the Chlorantraniliprole market is segmented into chlorantraniliprole market is classified into suspension concentrate, water dispersible granules, chlorantraniliprole mixtures, and others.
Based on application, the Chlorantraniliprole market is segmented into rice, soy, fruits and vegetables, corn and others.

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.

This release was published on openPR.